1971 related articles for article (PubMed ID: 31027964)
1. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
2. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis.
Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?
Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
J Pharm Policy Pract; 2021 May; 14(1):42. PubMed ID: 33958004
[TBL] [Abstract][Full Text] [Related]
4. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
5. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
Fathima M; Saini B; Foster JM; Armour CL
Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
[TBL] [Abstract][Full Text] [Related]
6. A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.
Nik J; Lai PS; Ng CJ; Emmerton L
BMC Health Serv Res; 2016 Aug; 16(1):448. PubMed ID: 27577560
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' experiences and views on providing screening services: An international comparison.
Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I
Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
[TBL] [Abstract][Full Text] [Related]
10. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
Yong FR; Hor SY; Bajorek BV
BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
Wibowo Y; Sunderland B; Hughes J
Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
[TBL] [Abstract][Full Text] [Related]
12. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
[TBL] [Abstract][Full Text] [Related]
15. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
16. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
Katoue MG
J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
[TBL] [Abstract][Full Text] [Related]
18. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
Sato N; Fujita K; Kushida K; Chen TF
Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
20. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
